Scarica l'app Stockscreener
2.1041
2.13%
-0.0459
Precedente Chiudi:
$2.15
Aprire:
$2.18
Volume 24 ore:
19,561
Relative Volume:
0.11
Capitalizzazione di mercato:
$3.69M
Reddito:
$72,100
Utile/perdita netta:
$-4.84M
Rapporto P/E:
-0.2822
EPS:
-7.4566
Flusso di cassa netto:
$-3.84M
1 W Prestazione:
-14.12%
1M Prestazione:
-44.34%
6M Prestazione:
-59.55%
1 anno Prestazione:
-78.06%
Intervallo 1D:
$2.10
$2.39
Intervallo di 1 settimana:
$2.10
$2.50
Portata 52W:
$2.10
$15.15
Silo Pharma Inc Stock (SILO) Company Profile
Nome
Silo Pharma Inc
Settore
Industria
Telefono
(718) 400-9031
Indirizzo
677 N. WASHINGTON BLVD, SARASOTA
Compare SILO vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SILO
SILO PHARMA INC
|
1.71 | 17.96M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
1.395 | 1.79B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
4.14 | 698.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
19.67 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.23 | 226.24M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
8.07 | 197.39M | 0 | 0 | 0 | 0.00 |
Silo Pharma Inc Borsa (SILO) Ultime notizie
SpaceX Stock Price Today | SPCX Ticker, News, Retail Sentiment - Stocktwits
Silo Pharma Highlights Patented Nose-To-Brain Drug Delivery Technology for PTSD at 2026 Nasal Innovation Forum - marketscreener.com
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15 - citybuzz -
Silo Pharma to Participate in IPAC-RS 2026 Nasal Innovation Forum as It Advances SPC-15 Development - quiverquant.com
A nasal PTSD treatment met specs for nine months - Stock Titan
Silo Pharma Stock Price Forecast. Should You Buy SILO? - StockInvest.us
Silo Pharma Inc (NYSE: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma Inc (NASDAQ: SILO) Share Price, SILO Stock News, SILO Share Price & Updates - Kalkine
Silo Pharma Inc (SILO) Peer Comparison – Compare with Others - Value Research
Silo Pharma Inc (SILO) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Silo Pharma Acquires Digital Assets via Stock Issuance - The Globe and Mail
Form 8K Silo Pharma Inc For: 19 August By Investing.com - Investing.com South Africa
Form 8K Silo Pharma Inc For: 19 August - Investing.com India
Silo Pharma Acquires Software and IP From Parkview Consulting for 165,000 Shares - TradingView
Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting - TradingView
Silo Pharma receives Canadian patent allowance for SPC-15 drug By Investing.com - Investing.com Canada
Silo Pharma Receives Notice of Allowance for Canadian Patent Application for Novel PTSD Treatment - The Manila Times
Silo Pharma Receives Notice of Allowance for Canadian Patent Application Covering Lead Asset Spc-15 Targeting Ptsd and Other Stress-Induced Psychiatric Disorders - marketscreener.com
Silo (SILO) Technical Check: Adds 1.95% to Close at $3.13; Range and Risk: the $2.97 to $3.29 Range Remains in Focus in the Current UpdateSuperTrend - Vinanet
Silo Pharma Shareholders Approve Major Share Authorization Expansion - TipRanks
Silo Pharma (SILO) holders approve lifting share cap from 6.7M - Stock Titan
Silo Pharma (SILO) Slips 0.62% to $3.20 as Shares Consolidate Between Key Technical LevelsStock Picks - Vinanet
Silo Pharma (SILO) trims cash burn, mitigates going-concern risk in Q2 2026 - Stock Titan
Silo Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Silo Pharma (SILO) investor group discloses 9.99% warrant-based ownership cap - Stock Titan
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on February 23, 2026. - marketscreener.com
Silo Pharma receives European patent for SPC-15 PTSD treatment By Investing.com - Investing.com South Africa
Silo Pharma Granted European Patent Covering Novel PTSD Therapy - The Manila Times
Silo Pharma receives European patent for SPC-15 PTSD treatment - Investing.com India
Silo Pharma Announces European Patent Grant for SPC-15 PTSD Prevention Therapy - Quiver Quantitative
SILO Q4 2023 Earnings: Wider-than-Expected Loss of -$5.40 per Share Highlights Heavy Pre-Revenue InvestmentTax Rate Impact - vinanet.vn
Silo Pharma Inc (SILO) Stock News Today - TradingKey
SILO Forecast & Price Target - TradingKey
Silo Pharma, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Silo Pharma (SILO) Q4 2023 Earnings: Wider-Than-Expected Loss Sends Shares Down 20%Quarterly Earnings - vinanet.vn
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform - marketscreener.com
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon - GlobeNewswire
SILO|Silo Pharma Inc|Price:3.200|Chg%:-0.020 - TradingKey
SILO Q4 2023 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage R&D SpendingQuarterly Earnings Report - vinanet.vn
Silo Pharma, Inc. Revenue Breakdown – NASDAQ:SILO - TradingView
Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Silo Pharma Inc. Q4 2023 Earnings: Wider-Than-Expected Loss Weighs on SharesHigh Estimate Range - vinanet.vn
Silo Pharma Inc (SILO) Income Statement - TradingKey
SILO|Silo Pharma Inc|Price:4.470|Chg%:+0.010 - TradingKey
Silo Pharma Inc (SILO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Silo Pharma Inc (SILO) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
Form S-3 Silo Pharma Inc For: 24 July By Investing.com - Investing.com India
Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common StockSEC Filing - TradingView
SILO Q4 2023 Earnings: Significant EPS Miss Highlights Operational ChallengesEarnings Volatility Report - vinanet.vn
Silo Pharma Inc Azioni (SILO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):